Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population

Shock

Volumn 31, Issue 4, 2009, Pages 342-347

  Kotanidou, Anastasia ^a   Karsaliakos, Petros ^a   Tzanela, Marinella ^b   Mavrou, Irini ^a   Kopterides, Petros ^a   Papadomichelakis, Evangelos ^a   Theodorakopoulou, Maria ^a   Botoula, Efi ^b   Tsangaris, Iraklis ^a   Lignos, Michalis ^a   Ikonomidis, Ignatios ^c   Ilias, Ioannis ^a   Armaganidis, Apostolos ^c   Orfanos, Stylianos E ^a   Dimopoulou, Ioanna ^a,d  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^d Critical Care Medicine   (Greece)

Author keywords

B type natriuretic peptide; Critical illness; Cytokines; Organ dysfunction; Prognosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; APACHE; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SURVIVOR; VENTILATED PATIENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APACHE; CRITICAL ILLNESS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 64849113221     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31818635b6     Document Type: Article

References (37)

1. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339:321-328, 1998.
2. Hall C: Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 15:257-260, 2004.
3. Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Conn JN: Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-Heft) data. Clin Chem 52:1528-1538, 2006.
4. Richards AM, Lainchbury JG, Troughton RW, Espiner EA, Nicholls MG: Clinical applications of B-type natriuretic peptides. Trends Endocrinol Metab 15:170-174, 2004.
5. de Lemos JA, McGuire DK, Drazner MH: B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322, 2003.
6. Burke MA, Cotts WG: Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev 12:23-36, 2007.
7. McLean AS, Tang B, Nalos M, Huang SJ, Stewart DE: Increased B-type natriuretic peptide (BNP) level is a strong predictor for cardiac dysfunction in intensive care unit patients. Anaesth Intensive Care 31:21-27, 2003.
8. Jefic D, Lee JW, Jefic D, Savoy-Moore RT, Rosman S: Utility of B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 128:288-295, 2005.
9. Karmpaliotis D, Kirtane AJ, Ruisi CP, Polonsky T, Malhotra A, Talmor D, Kosmidou I, Jarolim P, de Lemos JA, Sabatine MS, et al.: Diagnostic and prognostic utility of brain natriuretic peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema. Chest 131:964-971, 2007.
10. Mekontso-Dessap A, de Prost N, Girou E, Braconnier F, Lemaire F, Brun- Buisson C, Brochard L: B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 32:1529-1536, 2006.
11. Tung RH, Garcia C, Morss AM, Pino RM, Fifer MA, Thompson BT, Lewandrowski K, Lee-Lewandrowski E, Januzzi JL: Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock. Crit Care Med 32:1643-1647, 2004.
12. Forfia PR, Watkins SP, Rame JE, Stewart KJ, Shapiro EP: Relationship between B-type natriuretic peptides and pulmonary wedge pressure in the intensive care unit. J Am Coll Cardiol 45:1667-1671, 2005.
13. Berendes E, Van Aken H, Raufhake C, Schmidt C, Assmann G, Walter M: Differential secretion of atrial and brain natriuretic peptide in critically ill patients. Anesth Analg 93:676-682, 2001.
14. Cuthbertson BH, Patel RR, Goal BL, Barclay J, Hillis GS: B-type natriuretic peptide and the prediction of outcome in patients admitted to intensive care. Anaesthesia 60:16-21, 2005.
15. Almog Y, Novack V, Megralishvilli R, Kobal S, Barski L, King D, Zahger D: Plasma level of N terminal pro-brain natriuretic peptide as a prognostic marker in critically ill patients. Anesth Analg 102:1809-1815, 2006.
16. Meyer B, Huelsmann M, Wexberg P, Karth GD, Berger R, Moerti D, Szekeres T, Pachner R, Heinz G: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 35:2268-2273, 2007.
17. Shah KB, Nolan MM, Rao K, Wang DJ, Christenson RH, Shanhotz CB, Mehra MR, Gottlieb SS: The characteristics and prognostic importance of NT-proBNP concentrations in critically ill patients. Am J Med 120: 1071-1077, 2007.
18. Oberholzer A, Oberholzer C, Moldawer LL, Mitchell P: Cytokine signalingregulation of the immune response in normal and critically ill states. Crit Care Med 28(4 suppl):N3-N12, 2000.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE JJ: a severity of disease classification system. Crit Care Med 13:818-829, 1985.
20. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S: Use of SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26:1793-1800, 1998.
21. Levy M, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 31:1250-1256, 2003.
22. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Lianos J, Santalo-Bel M, Pinto YM, Richards M: NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients. Eur Heart J 27:330-337, 2006.
23. Maeder M, Fehr T, Rickli H, Ammann P: Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 129:1349-1366, 2006.
24. Witthaut R, Busch C, Fraunberger P, Walli A, Seidel D, Pilz G, Stuttmann N, Vemer L, Werdan K: Plasma natriuretic peptide and brain natriuretic peptide are increased in septic shock: impact of interleukin-6 and sepsis-associated left ventricular dysfunction. Intensive Care Med 29:1696-1702, 2003.
25. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 32:660-665, 2004.
26. Chua G, Kang-Hoe L: Marked elevations in N-terminal brain natriuretic peptide levels in septic shock. Crit Care 8:R248-R250, 2004.
27. 2 terminal pro-brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients. Crit Care Med 33:1001-1007, 2005.
28. Morgenthaler NG, Struck J, Christ-Crain M, Bergman A, Muller B: Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37-R45, 2005.
29. Brueckmann M, Huhle G, Lang S, Haase KK, Bertsch T, Weiss C, Kaden JJ, Putensen C, Borggrefe M, Hoffmann U: Prognostic value of plasma N- terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation 112:527-534,2005.
30. Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M: Comparable increase of B-type natriuretic peptide and aminoterminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, arid acute heart failure. Crit Care Med 34:2140-2144, 2006.
31. Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K: Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 26:134-139, 20Q6.
32. McLean AS, Huang SJ, Hyams S, Poh G, Nalos M, Pandit R, Balik M, Tang B, Seppelt I: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 35:1019-1026, 2007.
33. Varpula M, Pulkki K, Karlsson S, Ruokonen E, Pettila V: Predictive value of N-terminal pro-brain natriuretic peptide in severe sepsis and septic shock. Crit Care Med 35:1277-1283, 2007.
34. Phua J, Koay ESC, Lee KH: Lactate, procalcitonin, and amincrterminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 29:328-333, 2008.
35. Friese RS, Dineen S, Jennings A, Pruitt J, McBride D, Shafi S, Frankel H, Gentilello LM: Serum B-type natriuretic peptide: a marker of fluid resuscitation after injury? J Trauma 62:1346-1351, 2007.
36. Yap LB, Mukerjee D, Timms PM, Ashrafian H, Coghlan JG: Natriuretic peptides, respiratory disease, and the right heart. Chest 126:1330-1336, 2004.
37. McLean AS, Huang SJ, Nalos M, Tang B, Stewart DE: The corrfounding effects of age, gender, serum creatinine, and electrolyte concentrations on plasma B-type natriuretic peptide concentrations in critically ill patients. Crit Care Med 31:2611-2618, 2003.